Coccidioidomycosis. Two case reports with discussion of current diagnostic and therapeutic issues;Kokzidioidomykose. Zwei fallberichte mit diskussion aktueller diagnostik- und therapiemöglichkeiten

Hautarzt

Volumn 55, Issue 12, 2004, Pages 1143-1149

  Meier, F ^a,c   Tintelnot, K ^b   Metzler, G ^a   Schmidt, S ^a   Walker, B ^a   Scherwitz, C ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Coccidioidomycosis; Fluconazole; Fungal serology; Itraconazole; Posaconazole; Voriconazole

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

COCCIDIOIDOMYCOSIS; FOLLOW UP; HUMAN; LUNG INFILTRATE; RELAPSE; RESPIRATORY TRACT INFECTION; REVIEW; SEROLOGY; UNITED STATES;

ADMINISTRATION, ORAL; AGED; ANTIFUNGAL AGENTS; COCCIDIOIDOMYCOSIS; DERMATOMYCOSES; HUMANS; ITRACONAZOLE; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PROGNOSIS; TREATMENT OUTCOME;

EID: 11244331566     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-004-0782-8     Document Type: Review

References (28)

1. Ampel NM (2001) Coccidioidomycosis among persons with human immunodeficiency virus infection in the era of highly active antiretroviral therapy (HAART). Semin Respir Infect 16:257-262
2. Bayer AS (1981) Fungal pneumonias: pulmonary coccidioidal syndromes (Part 2). Miliary, nodular, and cavitary pulmonary coccidioidomycosis; chemotherapeutic and surgical considerations. Chest 79:686-691
3. Carroll GF, Haley LD, Brown JM (1977) Primary cutaneous coccidioidomycosis: a review of the literature and a report of a new case. Arch Dermatol 113:933-936
4. Clemons KV, Stevens DA (2000) Efficacies of sordarin derivatives GM193663, GM211676, and GM237354 in a murine model of systemic coccidioidomycosis. Antimicrob Agents Chemother 44:1874-1877
5. Corry DB, Ampel NM, Christian L et al. (1996) Cytokine production by peripheral blood mononuclear cells in human coccidioidomycosis. J Infect Dis 174:440-443
6. Cortez KJ, Walsh TJ, Bennett JE (2003) Successful treatment of coccidioidal meningitis with voriconazole. Clin Infect Dis 36:1619-1622
7. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases (1987) Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 36 [Suppl 1]:1S-15S
8. Deresinski SC (2001) Coccidioidomycosis: efficacy of new agents and future prospects. Curr Opin Infect Dis 14:693-696
9. Galgiani JN (1997) Coccidioidomycosis. Curr Clin Top Infect Dis 17:188-204
10. Galgiani JN (1999) Coccidioidomycosis: a regional disease of national importance. Rethinking approaches for control. Ann Intern Med 130:293-300
11. Galgiani JN, Catanzaro A, Cloud GA et al. (2000) Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group. Ann Intern Med 133:676-686
12. Gonzalez GM, Tijerina R, Najvar LK et al. (2001) Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model. Antimicrob Agents Chemother 45:1854-1859
13. Gonzalez GM, Tijerina R, Najvar LK et al. (2002) In vitro and in vivo activities of posaconazole against Coccidioides immitis. Antimicrob Agents Chemother 46:1352-1356
14. Kim A, Parker SS (2002) Coccidioidomycosis: case report and update on diagnosis and management. J Am Acad Dermatol 46:743-747
15. Kutzner H, Argenyi ZB, Requena L et al. (1998) A new application of BCG antibody for rapid screening of various tissue microorganisms. J Am Acad Dermatol 38:56-60
16. Larwood TR (2000) Coccidioidin skin testing in Kern County, California: decrease in infection rate over 58 years. Clin Infect Dis 30:612-613
17. Li RK, Ciblak MA, Nordoff N et al. (2000) In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Antimicrob Agents Chemother 44:1734-1736
18. Lutz JE, Clemons KV, Aristizabal BH, Stevens DA (1997) Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis. Antimicrob Agents Chemother 41:1558-1561
19. Mirels LF, Stevens DA (1997) Update on treatment of coccidioidomycosis. West J Med 166:58-59
20. Padhye AA, Smith G, Standard PG et al. (1994) Comparative evaluation of chemiluminescent DNA probe assays and exoantigen tests for rapid identification of Blastomyces dermatitidis and Coccidioides immitis. J Clin Microbiol 32:867-870
21. Pappagianis D, Einstein H (1978) Tempest from Tehachapi takes toll or Coccidioides conveyed aloft and afar. West J Med 129:527-530
22. Salfelder K (2000) Pilzinfektionen beim Menschen. OmniMed® Verlagsgesellschaft, Hamburg Zürich
23. Schlotfeldt D, Tintelnot K, Otto C (1991) Interpretation of clinical and serologic findings -1 1/2 years after a long-term coccidioidomycosis. Immun Infekt 19:121-123
24. Scott P (1993) IL-12: initiation cytokine for cell-mediated immunity. Science 260:496-497
25. Shapira SK, Jabara HH, Thienes CP et al. (1991) Deletional switch recombination occurs in interleukin-4-induced isotype switching to IgE expression by human B cells. Proc Natl Acad Sci USA 88:7528-7532
26. Stevens DA (1995) Coccidioidomycosis. N Engl J Med 332:1077-1082
27. Tucker RM, Denning DW, Arathoon EG et al. (1990) Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations. J Am Acad Dermatol 23:593-601
28. Vaz A, Pineda-Roman M, Thomas AR, Carlson RW (1998) Coccidioidomycosis: an update. Hosp Pract (Off Ed) 33:105-118, 113-115, 119-120